Mycophenolatemofetil Accord (Mycophenolate Mofetil)

• Mycophenolate Mofetil is used in immunosuppressive regimens that target lymphocyte proliferation in transplant and autoimmune settings.
• Organ transplant rejection: helps prevent graft rejection in kidney, heart, liver and other transplanted organs.
• Lupus nephritis: reduces renal inflammation and proteinuria in patients with systemic lupus erythematosus.
• Other autoimmune diseases: contributes to disease control in conditions such as vasculitis and dermatomyositis.

• Mycophenolate Mofetil is converted in vivo to mycophenolic acid, which selectively inhibits inosine monophosphate dehydrogenase (IMPDH). This blocks de novo guanosine nucleotide synthesis, a pathway essential for proliferation of T and B lymphocytes, thereby suppressing the immune response without markedly affecting other cell types.

Adverse reactions may range from mild to severe and should be monitored throughout therapy.

Common Side Effects

• Nausea and vomiting
• Diarrhea or loose stools
• Abdominal pain or cramping
• Headache
• Upper respiratory tract infections
• Decreased appetite

Serious or Rare Side Effects

• Leukopenia or severe neutropenia
• Anemia or thrombocytopenia
• Opportunistic infections (e.g., CMV, PCP)
• Hepatic dysfunction or elevated transaminases
• Malignancies, particularly lymphoproliferative disorders
• Teratogenic effects leading to fetal harm

• Patients receiving Mycophenolatemofetil should be observed for hematologic and infectious complications, as well as organ‑specific toxicity.
• Monitor blood counts: perform regular CBC to detect leukopenia or anemia.
• Assess liver function: check transaminases and bilirubin periodically.
• Screen for infections: evaluate for viral, bacterial or fungal infections before and during therapy.
• Avoid pregnancy: drug is contraindicated in pregnancy (Category X) and effective contraception is required.
• Vaccination caution: live vaccines should be avoided while on treatment.
• Store at room temperature below 25°C: keep in the original container, protect from moisture and light.

Mycophenolate Mofetil can interact with several agents that affect its absorption or metabolism.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: reduce drug absorption.
• Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole): increase mycophenolic acid exposure.
• Live vaccines: heightened risk of infection.

Moderate Interactions (Monitor Closely)

• Azathioprine or other bone‑marrow suppressants: additive hematologic toxicity.
• Warfarin: may potentiate anticoagulant effect, requiring INR monitoring.
• Non‑live vaccines: monitor immune response effectiveness.
• High‑dose steroids: may increase infection risk.
• Renal‑impairing drugs: adjust monitoring of renal function.